Cargando…
Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue
OBJECTIVE: Oral squamous cell carcinoma (OSCC) accounts for over 90% of oral neoplasms. Finding molecular markers for predicting prognosis is a high priority. The core transcription factors, OCT4, SOX2, and NANOG that regulate embryonic stem cell pluripotency have been implicated in progression of v...
Autores principales: | Baghai Naini, Fereshteh, Amini Shakib, Pouyan, Abdollahi, Alireza, Hodjat, Mahshid, Mohammadpour, Hadiseh, Kardouni Khoozestani, Neda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021633/ https://www.ncbi.nlm.nih.gov/pubmed/31244283 http://dx.doi.org/10.31557/APJCP.2019.20.6.1649 |
Ejemplares similares
-
Assessment of the association of OCT3/4 with GLUT1 and CD105 in oral squamous cell carcinoma using dual immunohistochemistry
por: Derakhshan, Samira, et al.
Publicado: (2022) -
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020) -
Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023) -
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
por: Robinson, Mikella, et al.
Publicado: (2021) -
SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2
por: Wu, Yongyan, et al.
Publicado: (2012)